MX350435B - Composicion para uso en el crecimiento del cerebro y/o desarrollo cognitivo y/o desarrollo psicomotor. - Google Patents
Composicion para uso en el crecimiento del cerebro y/o desarrollo cognitivo y/o desarrollo psicomotor.Info
- Publication number
- MX350435B MX350435B MX2014004716A MX2014004716A MX350435B MX 350435 B MX350435 B MX 350435B MX 2014004716 A MX2014004716 A MX 2014004716A MX 2014004716 A MX2014004716 A MX 2014004716A MX 350435 B MX350435 B MX 350435B
- Authority
- MX
- Mexico
- Prior art keywords
- composition
- cognitive
- brain growth
- psychomotor development
- oligosaccharide
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 5
- 210000004556 brain Anatomy 0.000 title abstract 2
- 230000008133 cognitive development Effects 0.000 title abstract 2
- 230000008132 psychomotor development Effects 0.000 title abstract 2
- 229920001542 oligosaccharide Polymers 0.000 abstract 4
- 150000002482 oligosaccharides Chemical class 0.000 abstract 4
- 235000020978 long-chain polyunsaturated fatty acids Nutrition 0.000 abstract 1
- 230000007935 neutral effect Effects 0.000 abstract 1
- 239000006041 probiotic Substances 0.000 abstract 1
- 230000000529 probiotic effect Effects 0.000 abstract 1
- 235000018291 probiotics Nutrition 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K2035/11—Medicinal preparations comprising living procariotic cells
- A61K2035/115—Probiotics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Botany (AREA)
- Hematology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pediatric Medicine (AREA)
- Psychology (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11185600 | 2011-10-18 | ||
| PCT/EP2012/070281 WO2013057049A1 (en) | 2011-10-18 | 2012-10-12 | Composition for use in brain growth and/or cognitive and/or psychomotor development |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2014004716A MX2014004716A (es) | 2015-02-05 |
| MX350435B true MX350435B (es) | 2017-09-06 |
Family
ID=47019022
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2014004716A MX350435B (es) | 2011-10-18 | 2012-10-12 | Composicion para uso en el crecimiento del cerebro y/o desarrollo cognitivo y/o desarrollo psicomotor. |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20140271562A1 (OSRAM) |
| EP (2) | EP3095331A1 (OSRAM) |
| CN (1) | CN103889238B (OSRAM) |
| AU (1) | AU2012325060B2 (OSRAM) |
| BR (1) | BR112014008944B1 (OSRAM) |
| CL (1) | CL2014000759A1 (OSRAM) |
| ES (1) | ES2601891T3 (OSRAM) |
| IN (1) | IN2014DN01468A (OSRAM) |
| MX (1) | MX350435B (OSRAM) |
| MY (1) | MY170185A (OSRAM) |
| PH (1) | PH12014500443A1 (OSRAM) |
| PL (1) | PL2775852T3 (OSRAM) |
| PT (1) | PT2775852T (OSRAM) |
| RU (1) | RU2607458C2 (OSRAM) |
| WO (1) | WO2013057049A1 (OSRAM) |
| ZA (1) | ZA201403591B (OSRAM) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3248605A1 (en) | 2009-07-06 | 2017-11-29 | Children's Hospital Medical Center | Inhibiting inflammation with milk oligosaccharides |
| DK2708145T3 (en) | 2012-09-14 | 2016-07-18 | Abbott Lab | Nutritional Compositions for Use in Methods to Modulate Corticosterone Levels in Psychologically Stressed Individuals |
| EP3704957A1 (en) | 2012-09-14 | 2020-09-09 | Abbott Laboratories | Methods for increasing brain functionality using 2-fucosyl-lactose |
| EP2880993A1 (en) * | 2013-12-04 | 2015-06-10 | Abbott Laboratories | Method of achieving memory and learning improvement by the administration of sialic acid |
| EP3082473A2 (en) * | 2013-12-19 | 2016-10-26 | Nestec S.A. | Nutritional composition to reduce metabolic stress in infants |
| US20150305385A1 (en) * | 2014-04-25 | 2015-10-29 | Mead Johnson Nutrition Company | Pediatric nutritional composition with human milk oligosaccahrides, prebiotics and probiotics |
| FR3020949B1 (fr) * | 2014-05-16 | 2018-02-09 | Ecole Normale Superieure De Lyon | Composition permettant de favoriser la croissance juvenile humaine et animale en cas de malnutrition |
| EP3212012A1 (en) * | 2014-10-31 | 2017-09-06 | Nestec S.A. | Composition comprising fut2-dependent oligosaccharides and lacto-n-neotetraose for use in promoting brain development and cognition |
| CN106998775A (zh) * | 2014-11-26 | 2017-08-01 | 雅培制药有限公司 | 具有RRR‑α‑生育酚、2’‑岩藻糖基乳糖和益生菌的婴儿配方 |
| WO2016145628A1 (en) * | 2015-03-18 | 2016-09-22 | Nestec S.A. | Composition comprising siallyllactose for use in enhancing learning skills and memory function |
| WO2016176484A1 (en) | 2015-04-28 | 2016-11-03 | Children's Hospital Medical Center | Use of oligosaccharide compositions to enhance weight gain |
| CN107847509B (zh) * | 2015-08-04 | 2021-06-01 | 雀巢产品有限公司 | 具有2FL和LNnT的营养组合物 |
| ES2759556T3 (es) | 2015-12-15 | 2020-05-11 | Nestle Sa | Mezcla de oligosacáricos de la leche humana |
| US20210205340A1 (en) * | 2016-01-26 | 2021-07-08 | Nestec S.A. | Compositions comprising sialylated oligosaccharides for use in infants or young children to prevent later in life obesity or related comorbidities and promote a healthy growth |
| RU2735250C2 (ru) * | 2016-01-26 | 2020-10-29 | Сосьете Де Продюи Нестле С.А. | КОМПОЗИЦИЯ, СОДЕРЖАЩАЯ 2FL И LNnT, ДЛЯ КОНТРОЛЯ ПОТРЕБЛЕНИЯ ПИЩИ И РОСТА У МЛАДЕНЦЕВ ИЛИ ДЕТЕЙ МЛАДШЕГО ВОЗРАСТА |
| EP3443969B1 (en) * | 2016-04-13 | 2021-12-22 | Meiji Co., Ltd. | Use of bifidobacteria for improving developmental quotient in neonates |
| CN109715169A (zh) | 2016-07-28 | 2019-05-03 | 方塔拉合作集团有限公司 | 乳制品和工艺 |
| EP3565421A4 (en) | 2017-05-04 | 2020-07-22 | The Board of Trustees of the Leland Stanford Junior University | FOOD COMPOSITIONS PROMOTING NEUROLOGICAL DEVELOPMENT AND ASSOCIATED KITS, SYSTEMS AND PROCESSES |
| EP3624786B1 (en) | 2017-05-16 | 2023-07-05 | Ability Pharmaceuticals S.L. | A pharmaceutical combination for the treatment of a cancer |
| WO2018215406A1 (en) * | 2017-05-24 | 2018-11-29 | Nestec S.A. | A nutritional composition for use to enhance attention and/or reduce impulsivity |
| WO2019008104A1 (en) * | 2017-07-07 | 2019-01-10 | Nestec S.A. | FORTIFYING HUMAN MILK |
| WO2019008105A1 (en) * | 2017-07-07 | 2019-01-10 | Nestec S.A. | FORTIFYING HUMAN MILK |
| RU2698564C1 (ru) * | 2019-01-09 | 2019-08-28 | Федеральное государственное бюджетное учреждение "Уральский научно-исследовательский институт охраны материнства и младенчества" Министерства здравоохранения Российской Федерации (ФГБУ "НИИ ОММ" Минздрава России) | Способ прогнозирования риска развития гипотрофии у детей, родившихся в сроке сверхранних преждевременных родов, к скорригированному возрасту 6 месяцев |
| WO2022117710A1 (en) | 2020-12-04 | 2022-06-09 | Société des Produits Nestlé S.A. | Stable aqueous composition for preterm to promote early postnal growth |
| KR102570073B1 (ko) * | 2022-11-17 | 2023-08-24 | (주)에이피테크놀로지 | 2'-푸코실락토오스를 포함하는 치매 개선 또는 치료용조성물 |
| CN118285505A (zh) * | 2024-03-29 | 2024-07-05 | 黑龙江飞鹤乳业有限公司 | 促进大脑发育的营养组合物、食品及配方奶粉 |
| WO2025257135A1 (en) | 2024-06-10 | 2025-12-18 | N.V. Nutricia | Non-digestible oligosaccharide mixture for infants at risk of brain injury |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0481038B1 (en) | 1990-04-16 | 2002-10-02 | The Trustees Of The University Of Pennsylvania | Saccharide compositions, methods and apparatus for their synthesis |
| US5545553A (en) | 1994-09-26 | 1996-08-13 | The Rockefeller University | Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them |
| US20040048926A1 (en) * | 2002-03-15 | 2004-03-11 | Hoffman Dennis Robert | Use of docosahexaenoic acid and arachidonic acid to enhance the visual development of term infants breast-fed up to the age of six months |
| PT1638416E (pt) * | 2003-06-23 | 2013-07-08 | Nestec Sa | Utilização de uma fórmula nutricional para função de barreira intestinal óptima |
| CA2532489C (en) * | 2003-06-23 | 2012-12-11 | Nestec S.A. | Infant or follow-on formula |
| DE602004006133T3 (de) * | 2003-06-30 | 2014-12-24 | Clasado Inc. | Neue galactooligosaccharidzusammensetzung und herstellung davon |
| US20070166411A1 (en) * | 2005-12-16 | 2007-07-19 | Bristol-Myers Squibb Company | Nutritional supplement containing long-chain polyunsaturated fatty acids |
| MY146109A (en) | 2006-02-10 | 2012-06-29 | Nestec Sa | Oligosaccharide mixture |
| EP1993576B1 (en) | 2006-03-07 | 2015-10-21 | Nestec S.A. | Synbiotic mixture |
| US20080003330A1 (en) * | 2006-06-30 | 2008-01-03 | Ricardo Rueda | Infant formulas for early brain development |
| MX348901B (es) * | 2007-11-26 | 2017-07-03 | Nestec Sa | Sistema nutricional adaptado a la edad para infantes. |
| WO2010115935A1 (en) | 2009-04-07 | 2010-10-14 | Glycom A/S | Synthesis of 2 ' -o-fucosyllactose |
| EP2251030A1 (en) | 2009-05-12 | 2010-11-17 | Nestec S.A. | Lactoferrin and brain health and development in infants |
| EP2258216A1 (en) * | 2009-06-02 | 2010-12-08 | Nestec S.A. | Nutritional Composition for Supporting Brain Development and Function of Toddlers |
| EP2258218A1 (en) | 2009-06-02 | 2010-12-08 | Nestec S.A. | Nutritional Composition for Supporting Brain Development and Function of Toddlers |
| CN102481323A (zh) * | 2009-07-31 | 2012-05-30 | 雀巢产品技术援助有限公司 | 含有益生菌和所选营养物的用于母乳喂养的婴幼儿或宠物的营养组合物 |
| CN105330705A (zh) * | 2010-02-19 | 2016-02-17 | 格礼卡姆股份公司 | 用于制备含n-乙酰乳糖胺的四糖乳糖-n-新四糖(lnnt)的方法 |
| EP2404507A1 (en) | 2010-07-08 | 2012-01-11 | Nestec S.A. | Array of age-tailored nutritional formula with optimum fat content |
| RU2013158289A (ru) * | 2011-06-08 | 2015-07-20 | Нестек С.А. | Питательные композиции, содержащие экзогенные компоненты мембран жировых глобул молока |
-
2012
- 2012-10-12 CN CN201280051291.6A patent/CN103889238B/zh active Active
- 2012-10-12 MY MYPI2014700417A patent/MY170185A/en unknown
- 2012-10-12 PH PH1/2014/500443A patent/PH12014500443A1/en unknown
- 2012-10-12 ES ES12772784.0T patent/ES2601891T3/es active Active
- 2012-10-12 BR BR112014008944-2A patent/BR112014008944B1/pt active IP Right Grant
- 2012-10-12 MX MX2014004716A patent/MX350435B/es active IP Right Grant
- 2012-10-12 WO PCT/EP2012/070281 patent/WO2013057049A1/en not_active Ceased
- 2012-10-12 AU AU2012325060A patent/AU2012325060B2/en not_active Withdrawn - After Issue
- 2012-10-12 PL PL12772784T patent/PL2775852T3/pl unknown
- 2012-10-12 EP EP16174616.9A patent/EP3095331A1/en not_active Withdrawn
- 2012-10-12 EP EP12772784.0A patent/EP2775852B1/en active Active
- 2012-10-12 RU RU2014119844A patent/RU2607458C2/ru active
- 2012-10-12 IN IN1468DEN2014 patent/IN2014DN01468A/en unknown
- 2012-10-12 PT PT127727840T patent/PT2775852T/pt unknown
- 2012-10-12 US US14/352,236 patent/US20140271562A1/en not_active Abandoned
-
2014
- 2014-03-27 CL CL2014000759A patent/CL2014000759A1/es unknown
- 2014-05-16 ZA ZA2014/03591A patent/ZA201403591B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20140271562A1 (en) | 2014-09-18 |
| PH12014500443A1 (en) | 2014-04-14 |
| PT2775852T (pt) | 2016-11-08 |
| AU2012325060B2 (en) | 2015-11-19 |
| ZA201403591B (en) | 2016-01-27 |
| MY170185A (en) | 2019-07-09 |
| BR112014008944A2 (pt) | 2017-05-02 |
| CL2014000759A1 (es) | 2014-08-22 |
| CN103889238A (zh) | 2014-06-25 |
| CN103889238B (zh) | 2017-10-13 |
| BR112014008944B1 (pt) | 2020-09-15 |
| PL2775852T3 (pl) | 2017-02-28 |
| AU2012325060A1 (en) | 2014-03-13 |
| ES2601891T3 (es) | 2017-02-16 |
| MX2014004716A (es) | 2015-02-05 |
| RU2014119844A (ru) | 2015-11-27 |
| WO2013057049A1 (en) | 2013-04-25 |
| EP3095331A1 (en) | 2016-11-23 |
| EP2775852B1 (en) | 2016-08-17 |
| RU2607458C2 (ru) | 2017-01-10 |
| EP2775852A1 (en) | 2014-09-17 |
| IN2014DN01468A (OSRAM) | 2015-05-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY170185A (en) | Composition for use in brain growth and/or cognitive and/or psychomotor development | |
| MY173726A (en) | Synbiotics combination for brain improvement | |
| PH12014500509B1 (en) | Composition for use in the promotion of intestinal angiogenesis and of nutrient absorption and of enteral feeding tolerance and/or in the prevention and/or treatment of intestinal inflammation and/or in the recovery after intestinal injury and surgery | |
| PH12014500558A1 (en) | Composition for use in the promotion of healthy bone growth and/or in the prevention and/or treatment of bone disease | |
| PH12012501823A1 (en) | Infant nutrition for improving fatty acid composition of brain membranes | |
| PH12013502105A1 (en) | Nutritional products comprising human milk oligosaccharides and methods for manufacture thereof | |
| PH12017500387A1 (en) | Composition comprising fut2-dependent oligosaccharides and lacto-n-neotetraose for use in promoting brain development and cognition | |
| PH12014500075A1 (en) | Pharmaceutical composition, methods for treating and uses thereof | |
| PH12014500453A1 (en) | Composition for use in increasing insulin sensitivity and/or reducing insulin resistance | |
| IN2015DN00924A (OSRAM) | ||
| PH12018500035A1 (en) | Nutritional compositions and methods for promoting cognitive development | |
| BR112015013349A2 (pt) | trieptanoína para o tratamento de deficiência de transportador de glicose 1 | |
| PH12015501334B1 (en) | Milk-based nutritional compositions containing lactoferrin and uses thereof | |
| BR112012023328A2 (pt) | composições nutricionais | |
| PH12014500344A1 (en) | Composition for use in the promotion of magnesium absorption and/or magnesium retention | |
| WO2014194053A3 (en) | Carbohydrate compounds for nutritional and therapeutic use | |
| NZ626540A (en) | Glutamine enriched nutritional composition for preterm infants | |
| HK1201067A1 (en) | Sialic acid analogs | |
| PH12014501569A1 (en) | Glutamine enriched nutritional composition for preterm infants | |
| MX2012012324A (es) | Formulaciones y usos del derivado del acido 2 - hidroxi -5 - fenilazobenzoico para el tratamiento de varones. | |
| UA60256U (ru) | Способ патогенетической профилактики и лечения внутрижелудочковых кровоизлияний (вжк) у новорожденных | |
| UA52520U (ru) | Способ лечения нарушений функционального состояния кишечника у новорожденных и детей младенческого возраста | |
| TH146972A (th) | องค์ประกอบเพื่อใช้ในการพัฒนาการเติบโตของสมอง และ/หรือ การพัฒนาด้านสติปัญญา และ/หรือ การพัฒนาทางร่างกาย | |
| PL401911A1 (pl) | Zastosowanie preparatu o wlasciwosciach immunoregulatorowych | |
| UA94869C2 (ru) | Применение липофлавона в качестве средства для лечения острой черепно-мозговой травмы |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |